@buynholdisdead asked what IBD had to say about SMCI, here is my response…
Remember that IBD does not make specific buy and sell recommendations. They talk about stocks that are setting up or breaking out, and they will remind us of the sell rules when they apply, but they don’t send out “buy now” or “sell now” notices.
So let’s see what the charts say. First, look at the rankings in that top left box. Very, very strong IBD rankings, just what you are looking for. (99 means it is better than 99% of the stocks). Down in the bottom right the box shows great earnings and sales growth at the last earnings report. CANSLIM/IBD prefer a lot more of them to show up consecutively, but it looks like street consensus for earnings is to grow 89% in 2024.
Not long ago, I drew that downward trendline and made it an alert. The recent support at the 50dma and a crossing of that trendline would be very positive. Also not that the volume during the recent decline was declining, indicating less of a desire to sell. Yesterday, the price jumped above the trendline on volume slightly higher than recent volume. I decided not to buy because the market has become so weak. I thought I would wait until today and decide. Today (2PM), the price has faded below the trendline and the market has continued to be bad. In fact, if the market vol on Naz and S&P are up today, I believe IBD will change status from “Market Under Pressure” to “Market In Correction”. (Per IBD “rules”, the market status and feedback on my holdings has cause me to cut the majority of my IBD holdings over the last week).
4/16: IBD: “Super Micro stock soared 10.8% to 976.30, retaking the 50-day and 21-day lines and touching a downward-sloping trendline. Loop Capital hiked its SMCI stock price target to 1,500 from 1,000.
Investors could buy the AI server maker here for an early entry or wait for a move above Tuesday’s high. Super Micro stock is on track to have a base with a 1,229 buy point after this week.
Super Micro earnings are due on April 30, but often releases preliminary results a week or two before full financials.”
With its strong ratings and RS of 99 and recent support at the 50dma, this is definitely a stock to watch. Institutions are clearly not dumping it.